TESORIERE, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.942
EU - Europa 3.314
AS - Asia 2.519
SA - Sud America 343
AF - Africa 85
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 11.211
Nazione #
US - Stati Uniti d'America 4.859
SG - Singapore 856
RU - Federazione Russa 727
CN - Cina 717
IT - Italia 715
FI - Finlandia 499
UA - Ucraina 363
VN - Vietnam 263
BR - Brasile 257
HK - Hong Kong 228
DE - Germania 221
IE - Irlanda 172
PL - Polonia 140
GB - Regno Unito 119
FR - Francia 111
JP - Giappone 93
BD - Bangladesh 87
SE - Svezia 79
CA - Canada 39
KR - Corea 37
RO - Romania 37
NL - Olanda 33
TR - Turchia 33
IN - India 32
CI - Costa d'Avorio 25
AR - Argentina 24
IQ - Iraq 24
IR - Iran 23
MX - Messico 21
BE - Belgio 19
CO - Colombia 19
PK - Pakistan 18
ZA - Sudafrica 18
ES - Italia 16
AT - Austria 15
ID - Indonesia 13
MY - Malesia 12
VE - Venezuela 12
SA - Arabia Saudita 11
CH - Svizzera 10
NP - Nepal 10
EC - Ecuador 9
UZ - Uzbekistan 9
KE - Kenya 8
MA - Marocco 8
CL - Cile 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
HN - Honduras 6
TN - Tunisia 6
DZ - Algeria 5
GR - Grecia 5
JM - Giamaica 5
KZ - Kazakistan 5
PH - Filippine 5
PT - Portogallo 5
AZ - Azerbaigian 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
GE - Georgia 4
LT - Lituania 4
PY - Paraguay 4
UY - Uruguay 4
EG - Egitto 3
EU - Europa 3
IL - Israele 3
LB - Libano 3
NZ - Nuova Zelanda 3
PE - Perù 3
TW - Taiwan 3
AL - Albania 2
CG - Congo 2
CR - Costa Rica 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
MM - Myanmar 2
MT - Malta 2
NG - Nigeria 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GD - Grenada 1
IS - Islanda 1
KY - Cayman, isole 1
LV - Lettonia 1
Totale 11.202
Città #
Ashburn 572
Singapore 563
Fairfield 409
Chandler 318
San Jose 304
Woodbridge 272
Houston 270
Hong Kong 220
Wilmington 214
Jacksonville 203
Seattle 171
Dublin 157
Ann Arbor 155
Beijing 146
Palermo 134
Zgierz 122
Cambridge 119
Medford 103
Dallas 97
Moscow 90
Des Moines 89
Ho Chi Minh City 89
Nanjing 88
Tokyo 88
New York 80
Council Bluffs 71
Los Angeles 71
Hanoi 65
Santa Clara 65
Frankfurt am Main 63
Princeton 63
The Dalles 63
Boardman 57
Lauterbourg 51
Tulsa 47
Dearborn 43
Changsha 34
Jinan 33
Altamura 30
Buffalo 28
Hefei 28
Helsinki 26
Abidjan 25
Lawrence 25
Hebei 24
San Diego 24
Shenyang 24
Nanchang 23
São Paulo 21
Chicago 20
Brussels 19
Guangzhou 19
Orem 19
Tianjin 19
Milan 18
Amsterdam 17
Jiaxing 17
Atlanta 16
Da Nang 16
Verona 16
Rome 15
Baghdad 14
London 14
Bremen 13
Hangzhou 12
Menlo Park 12
Zhengzhou 12
Düsseldorf 11
Napoli 11
Venice 11
Brooklyn 10
City of London 10
Denver 10
Haiphong 10
Johannesburg 10
Kraków 10
Ludwigshafen am Rhein 10
Rio de Janeiro 10
Seoul 10
Ankara 9
Montreal 9
Brasília 8
Columbus 8
Frankfurt 8
Ninh Bình 8
Saint Petersburg 8
Tashkent 8
Tehran 8
Toronto 8
Cardiff 7
Istanbul 7
Izmir 7
Phoenix 7
Warsaw 7
Amman 6
Belo Horizonte 6
Can Tho 6
Curitiba 6
Dhaka 6
Lanzhou 6
Totale 6.641
Nome #
THE APOPTOTIC EFFECT INDUCED IN HepG2 CELLS BY INHIBITORS OF HISTONE DEACETYLASES IS CORRELATED WITH ACETYLATION OF p53 AND HISTONES. 416
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis 290
Retinoblastoma: History of His Identification, Characterization and Treatment 278
Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. 255
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways 252
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. 250
Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL. 243
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells. 242
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. 240
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. 240
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 228
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. 221
Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as an useful in vitro model to develop several purposes 219
Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors. 215
COINVOLGIMENTO DELLO STRESS DEL RETICOLO E DEL PROCESSO AUTOFAGICO NELL’APOPTOSI INDOTTA DAL CANNABINOIDE SINTETICO WIN IN CELLULE DI EPATOMA UMANO IN COLTURA 215
3AB-OS, a new human pluripotent cancer stem cell: properties and expectations for practical applications. 211
Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8. 209
Parthenolide induces caspase-independent cell death in osteosarcoma, melanoma and breast cancer cells through the induction of oxidative stress. 208
Janus-Faced role of microRNA let-7d in osteosarcoma 3AB-OS cancer stem cells 208
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation 205
Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). 201
Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. 197
Composizioni farmaceutiche per il trattamento di tumori epatici 197
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 197
The HDAC inhibitor SAHA synergistically stimulates the cytotoxic effect induced by Parthenolide in MDA-MB231 cells 195
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. 194
Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. 191
The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. 185
Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. 184
THE ROLE OF THE EXTRINSIC PATHWAY OF APOPTOSIS IN THE EFFECT INDUCED BY SAHA IN HUMAN HEPATOMA CELLS. 178
Parthenolide sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis 174
WIN55,212-2, a synthetic agonist of cannabinoid receptors, sensitizes tumor cells to TRAIL-induced apoptosis. 172
THE APOPTOTIC EFFECT EXERTED IN HUMAN HEPATOMA CELLS BY THE INHIBITOR OF HISTONE DEACETYLASE SAHA EITHER ALONE OR IN COMBINATION WITH BORTEZOMIB. 172
Histone deacetylase inhibitors in cancer therapy: Biological and clinical implications. 171
Histone deacetylase inhibitors: Epigenetic drugs acting by pleiotropic apoptotic mechanism in tumor cells and highly potent in combination with other antitumor agents. 170
Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231 170
APOPTOTIC EFFECTS INDUCED BY ANANDAMIDE IN HEPATIC CELLS. 168
The cytotoxic effect exerted by parthenolide and DMAPT on breast cancer stem-like cells 167
The synergistic effect exerted by the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide on triple negative breast canc er cells 162
HISTONE DEACETYLASE INHIBITORS SENSITIZE HEPATOMA CELLS TO TRAIL_INDUCED APOPTOSIS 159
The mechanism by which histone deacetylase inhibitors sensitize hepatoma and colon cancer cells to TRAIL-induced apoptosis 158
SYNERGISTIC APOPTOTIC INTERACTION BETWEEN THE HDAC INHIBITOR SAHA AND THE PROTEASOME INHIBITOR BORTEZOMIB IN HUMAN HEPATOMA CELLS. 156
Degradation of IkBalfa during apoptosis induced by proteasome inhibitors in hepatoma cells. 152
Synergistic interaction between Parthenolide and TRAIL induces apoptosis in human hepatocarcinoma cells. 149
Il partenolide sensibilizza le cellule di epatocarcinoma all'apoptosi indotta da TRAIL 145
Okadaic acid-Parthenolide combination at subtoxic doses induces potent synergistic apoptotic effects in human retinoblastoma Y79 cells by upregulating PTEN. 145
Synergistic apoptotic effect in HepG2 cells between bortezomib and hystone deacetylase inhibitors 141
JNK AND AP-1 MEDIATE APOPTOSIS INDUCED BY BORTEZOMIB IN HEPATOMA HEPG2 CELLS. 136
Quaderni del Dottorato di Ricerca in Oncobiologia Sperimentale: Tecniche e Procedure di Ricerca 134
Differentiative pathway induced by 3-aminobenzamide in MG-63 human osteosarcoma cells. 133
The proteasome inhibitor bortezomib in programmed cell death and cancer therapy 132
Proteasome inhibitor Velcade induces apoptosis in hepatoma HepG2 cells stimulating both the extrinsic and the intrinsic apoptotic pathways. 131
Synergistic effect of the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide in triple negative breast cancer cells. 131
New perspectives in tumor therapy: molecular aspects, 2006 129
The synthetic cannabinoid WIN sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by activating p8/CHOP/DR5 axis. 128
Role of the acetylation of p53 and histones in SAHA-induced apoptosis in human hepatoma HepG2 cells. 126
Role of PPARγ in apoptosis induced by cannabinoids in hepatoma HepG2 cells. 123
The transcription factor CHOP is critical for WIN-mediated DR5 up-regulation in apoptosis induced by WIN/TRAIL co-treatment in hepatoma cells 120
The involvement of the c-Jun/JNK/AP-1 pathway and HSPs in apoptosis induced by the proteasome inhibitor PS-341 (Velcade) in human hepatoma cells. 119
The cannabinoid WIN induces DR5 receptor expression in hepatoma cells sensitizing them to TRAIL signal 113
Synergistic effects induced by combinations of the synthetic cannabinoid WIN55,212-2 and the death receptor ligand TRAIL in hepatoma HepG2 cells. 111
SAHA induces acetylation of p53 and histones in human hepatoma HepG2 cells 109
THE CANNABINOID AGONIST WIN55,212-2 INDUCES APOPTOSIS IN HUMAN HEPATOMA CELLS. 105
Totale 11.475
Categoria #
all - tutte 35.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022643 39 156 13 18 10 15 20 22 98 98 24 130
2022/2023885 107 113 18 110 97 153 65 66 96 2 48 10
2023/2024397 20 65 24 47 31 85 25 34 6 3 9 48
2024/20251.004 20 86 59 70 42 55 53 50 51 99 160 259
2025/20264.135 280 143 251 240 377 592 571 442 279 572 190 198
2026/2027115 115 0 0 0 0 0 0 0 0 0 0 0
Totale 11.475